RDY - Company ID 0001135951
The table below shows DR REDDYS LABORATORIES LTD's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | $2.23B | $1.96B | $1.70B | $1.50B | $1.41B | $1.25B |
| R&D | $320.00M | $274.00M | $236.00M | $230.00M | $226.00M | $204.00M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.10B |
| $926.00M |
| $828.00M |
| $818.00M |
| $747.00M |
| $665.00M |
| Operating income | - | - | - | - | - | - |
| Income tax | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - |
| EPS (diluted) | - | - | - | - | - | - |